B-Type Natriuretic Peptide in Heart Failure With Preserved Ejection Fraction - Relevance to Age-Related Left

Eisaku Harada1, Yuji Mizuno1, Fumihito Kugimiya1

  • 1Division of Cardiovascular Medicine, Kumamoto Kinoh Hospital, Kumamoto Aging Research Institute.

Insights

Plasma B-type natriuretic peptide (BNP) levels are lower in heart failure with preserved ejection fraction (HFpEF) and linked to aging-related cardiac remodeling. This contrasts with heart failure with reduced ejection fraction (HFrEF), which shows eccentric hypertrophy.

Area of Science:

  • Cardiology
  • Biomarkers
  • Heart Failure Pathophysiology

Background:

  • Heart failure with preserved ejection fraction (HFpEF) is a growing concern, particularly in aging populations.
  • Plasma B-type natriuretic peptide (BNP) levels correlate with left ventricular (LV) dysfunction severity.
  • Understanding BNP in HFpEF is crucial for elucidating its pathogenesis compared to heart failure with reduced ejection fraction (HFrEF).

Purpose of the Study:

  • To investigate plasma B-type natriuretic peptide (BNP) levels in patients with HFpEF.
  • To compare BNP levels and associated cardiac characteristics between HFpEF and HFrEF.
  • To explore the relationship between BNP and LV remodeling in HFpEF.

Main Methods:

  • A cohort of 468 HFpEF patients and 126 HFrEF patients underwent echocardiography and clinical assessments, including plasma BNP measurement.
  • Demographic and clinical data, including age, sex, blood pressure, and LV parameters (diastolic dimensions, mass index, relative wall thickness), were analyzed.
  • Multiple regression analysis identified predictors of plasma BNP levels.

Main Results:

  • HFpEF patients were older, predominantly female, and had higher systolic and pulse pressures than HFrEF patients.
  • Plasma BNP levels, LV diastolic dimensions, and LV mass index (LVMI) were lower in HFpEF, while relative wall thickness was higher.
  • LVMI, ejection fraction (EF), albumin, C-reactive protein, and uric acid predicted BNP levels.

Conclusions:

  • Plasma BNP levels are lower in HFpEF and associated with aging-related LV concentric remodeling.
  • HFpEF differs from HFrEF, where LV hypertrophy is predominantly eccentric.
  • These findings highlight distinct pathophysiological mechanisms in HFpEF versus HFrEF.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...